Show simple item record

dc.contributor.authorKarikó, Katalin
dc.contributor.authorRutjes, Floris
dc.date.accessioned2023-03-14T13:31:25Z
dc.date.available2023-03-14T13:31:25Z
dc.date.issued2023
dc.identifier.urihttps://library.oapen.org/handle/20.500.12657/61694
dc.description.abstractOn 20 October 2022, the day that Radboud University celebrated its 99th anniversary, Dr. Katalin Karikó received a Radboud honorary doctorate in recognition of her scientific contributions to developing mRNA-based vaccines. This edition includes the laudatio of the honorary supervisor and the speech of the honorary doctor. Karikó spent years researching medical applications of mRNA. Her dream was to develop synthetic mRNA and use this to cure cancer, strokes, and influenza. Eventually, after years of toil, rejection, and criticism from colleagues, she and fellow researcher Drew Weissman demonstrated that it is possible to trigger an immune response in the body with mRNA without the body turning against the mRNA itself. With this breakthrough, a new revolutionary technique was born. Thanks to Karikó’s scientific work, BioNTech/Pfizer and Moderna were able to develop the current mRNA vaccines against COVID-19. A prime example of the beneficial impact that fundamental research can eventually have on society.en_US
dc.languageEnglishen_US
dc.subject.classificationthema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSB Biochemistryen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otherCOVID-19; mRNA vaccines; Honorary doctor; Honorary doctorateen_US
dc.titleHonorary Doctorate Dr. Katalin Karikóen_US
dc.title.alternative20th of October 2022en_US
dc.typebook
oapen.identifier.doi10.54195/BNYC2439en_US
oapen.relation.isPublishedBy3237ffdf-4cb3-49a0-8415-ceba8c0cba23en_US
oapen.relation.isbn9789493296008en_US
oapen.pages34en_US
oapen.place.publicationNijmegenen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record